From the Research
Dosing Regimen of Breztri
The usual dosing regimen of Breztri (budesonide, glycopyrrolate, and formoterol fumarate) is as follows:
- Budesonide/glycopyrrolate/formoterol fumarate metered-dose inhaler 320/18/9.6 μg, administered twice daily 1, 2, 3
- Budesonide/glycopyrrolate/formoterol fumarate metered-dose inhaler 160/18/9.6 μg, administered twice daily 2
Key Points
- The dosing regimen may vary depending on the patient's response to treatment and medical history 2, 4
- The use of a spacer with the metered-dose inhaler may improve drug delivery, especially for patients with suboptimal inhalation technique 5
- The safety and efficacy of Breztri have been evaluated in several clinical trials, including the KRONOS study 1, 3, 4 and a Phase I randomized crossover trial 5